- Home
- FCPT vs MRUS Comparison
FCPT vs MRUS Comparison
Compare FCPT & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCPT
- MRUS
- Stock Information
- Founded
- FCPT 2015
- MRUS 2003
- Country
- FCPT United States
- MRUS Netherlands
- Employees
- FCPT N/A
- MRUS N/A
- Industry
- FCPT Real Estate Investment Trusts
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- FCPT Real Estate
- MRUS Health Care
- Exchange
- FCPT Nasdaq
- MRUS Nasdaq
- Market Cap
- FCPT 2.9B
- MRUS 2.7B
- IPO Year
- FCPT N/A
- MRUS 2016
- Fundamental
- Price
- FCPT $28.24
- MRUS $43.06
- Analyst Decision
- FCPT Buy
- MRUS Strong Buy
- Analyst Count
- FCPT 7
- MRUS 13
- Target Price
- FCPT $30.50
- MRUS $86.85
- AVG Volume (30 Days)
- FCPT 1.0M
- MRUS 872.0K
- Earning Date
- FCPT 04-30-2025
- MRUS 05-07-2025
- Dividend Yield
- FCPT 5.12%
- MRUS N/A
- EPS Growth
- FCPT N/A
- MRUS N/A
- EPS
- FCPT 1.07
- MRUS N/A
- Revenue
- FCPT $268,072,999.00
- MRUS $36,133,000.00
- Revenue This Year
- FCPT $8.15
- MRUS $26.81
- Revenue Next Year
- FCPT $9.74
- MRUS $23.85
- P/E Ratio
- FCPT $26.39
- MRUS N/A
- Revenue Growth
- FCPT 6.97
- MRUS N/A
- 52 Week Low
- FCPT $22.38
- MRUS $33.19
- 52 Week High
- FCPT $30.93
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- FCPT 54.49
- MRUS 51.15
- Support Level
- FCPT $25.01
- MRUS $33.19
- Resistance Level
- FCPT $27.80
- MRUS $43.46
- Average True Range (ATR)
- FCPT 0.95
- MRUS 3.53
- MACD
- FCPT 0.05
- MRUS 0.34
- Stochastic Oscillator
- FCPT 81.57
- MRUS 80.53
About FCPT Four Corners Property Trust Inc.
Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.